|
covid-19 |
14 |
|
immune activation |
14 |
|
intestine |
14 |
|
replication |
14 |
|
sars-cov |
14 |
|
emt |
13 |
|
esophageal squamous cell carcinoma |
10 |
|
prognosis |
10 |
|
chemoradiotherapy |
9 |
|
gastric cancer |
9 |
|
oesophageal cancer |
9 |
|
oesophagectomy |
9 |
|
neoadjuvant therapy |
8 |
|
oesophageal squamous cell carcinoma |
8 |
|
advanced escc |
7 |
|
azygos vein blood |
7 |
|
chemoprevention |
7 |
|
circulating tumor cells (ctc) |
7 |
|
ctc clusters |
7 |
|
early prediction |
7 |
|
esophageal cancer |
7 |
|
helicobacter pylori |
7 |
|
immortal time bias |
7 |
|
liquid biopsy |
7 |
|
longitudinal real-time monitoring |
7 |
|
non-invasive biomarker |
7 |
|
nonsteroidal anti-inflammatory drugs |
7 |
|
computed tomography |
6 |
|
ctc |
6 |
|
deep learning |
6 |
|
escc |
6 |
|
esophagectomy |
6 |
|
gene expression |
6 |
|
lymphadenectomy |
6 |
|
neoadjuvant chemoradiotherapy |
6 |
|
radiogenomic |
6 |
|
radiomics |
6 |
|
twist1 |
6 |
|
xenograft |
6 |
|
esophageal cancer surgery |
5 |
|
la-tam |
5 |
|
lymph node metastasis |
5 |
|
multi-omics study |
5 |
|
neoadjuvant chemoradiation |
5 |
|
retrotransposon insertion |
5 |
|
spatial analysis |
5 |
|
calcium channel blockers |
4 |
|
h pylori |
4 |
|
aspiration |
3 |
|
calcium blood level |
3 |
|
cancer prognosis |
3 |
|
cancer surgery |
3 |
|
clinical article |
3 |
|
continuous intraoperative nerve monitoring |
3 |
|
coughing |
3 |
|
disease association |
3 |
|
hyperparathyroidism |
3 |
|
midline incision |
3 |
|
nerve monitoring |
3 |
|
parathyroid hormone blood level |
3 |
|
parathyroidectomy |
3 |
|
postoperative period |
3 |
|
radical gastrectomy surgery |
3 |
|
recurrent laryngeal nerve |
3 |
|
subcostal rooftop incision |
3 |
|
thoracoscopic esophagectomy |
3 |
|
aged |
2 |
|
aging |
2 |
|
anastomosis leakage |
2 |
|
cancer cell |
2 |
|
cancer chemotherapy |
2 |
|
cancer grading |
2 |
|
cancer mortality |
2 |
|
cancer radiotherapy |
2 |
|
combined modality therapy |
2 |
|
conversion surgery |
2 |
|
conversion therapy |
2 |
|
endoscopic mucosal resections |
2 |
|
endoscopic submucosal dissection |
2 |
|
esophageal achalasia |
2 |
|
esophageal motility disorders |
2 |
|
esophageal neoplasm |
2 |
|
esophageal neoplasms |
2 |
|
laparoscopic gastrectomy |
2 |
|
laparotomy |
2 |
|
natural orifice transluminal endoscopic surgery (notes) |
2 |
|
open gastrectomy |
2 |
|
pharyngolaryngoesophagectomy |
2 |
|
precancerous condition |
2 |
|
squamous cell carcinoma |
2 |
|
thoracotomy |
2 |
|
: consensus |
1 |
|
case report |
1 |
|
clinical staging |
1 |
|
dysphagia |
1 |
|
esophageal motility |
1 |
|
evidence-based medicine |
1 |
|
fundoplication |
1 |
|
gastroesophageal reflux disease |
1 |
|
heartburn |
1 |
|
high-resolution manometry |
1 |
|
lower esophageal sphincter |
1 |
|
multidisciplinary treatment |
1 |
|
regurgitation |
1 |
